Back

Usefulness of ECG in diagnosing hypertrophic cardiomyopathy

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in ventricular arrhythmias and sudden cardiac death (1) Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Irene Chung

Tan Tock Seng Hospital, Singapore (Singapore)

4 More presentations in this session

Presentation thumbnail
Cardiac magnetic resonance: the key for arrhythmic risk stratification in undiagnosed patients?
Doctor M. Paralta De Figueiredo (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Baseline intervals on electrocardiogram as a screening tool for diagnosing brugada syndrome in family members
Doctor F. Rodrigues Santos (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
Topographic analysis of premature ventricular contractions in heart failure with reduced and mildly reduced ejection fraction
Doctor E. Heidenhoffer (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
Istaroxime and its metabolite analogue reduce reperfusion arrhythmias in isolated-perfused diabetic rat hearts and anesthetized diabetic rats
Doctor S. Simonson (Kennett Square, US)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in ventricular arrhythmias and sudden cardiac death (1)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Examining ECG's performance as a screening method for hypertrophic cardiomyopathy: phenotypic correlations and evaluation
thumbnail
Congress Presentation
Decrease of ECG hypertrophy indices during mavacamten treatment in obstructive hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Effect of different phenotypes of hypertrophic cardiomyopathy on clinical outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources